Aussie Doctors Criticize Withdrawal Of Methadone Drug For Label Change
This article was originally published in PharmAsia News
Executive Summary
Australian physicians are complaining about what one termed "bureaucratic bungling" because Physeptone (methadone) has been pulled from shelves for a packaging redesign